Pacific Biosciences of California, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
Pacific Biosciences of California, Inc. (PACB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 2.02 million shares for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2013-08-09
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-06-30 was 185.00K shares.
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2013-03-31 was 1.84M shares.
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2012-12-31 was 1.21K shares.
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2012-09-30 was 437.00 shares.
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2012 was 4.72K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2013-06-30 | 185.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | 2.02M shares 10-Q · filed 2013-08-09 | 2.03M shares derived: sum of 3 quarters · filed 2013-08-09 | 2.03M shares derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | 1.84M shares 10-Q · filed 2013-05-10 | 1.84M shares derived: sum of 2 quarters · filed 2013-05-10 | 1.84M shares derived: sum of 3 quarters · filed 2013-05-10 | |
| 2012-12-31 | 1.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | 1.65K shares derived: sum of 2 quarters · filed 2013-03-15 | 4.72K shares 10-K · filed 2013-03-15 | |
| 2012-09-30 | 437.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | 3.51K shares 10-Q · filed 2012-11-01 | ||
| 2012-06-30 | 3.07K shares 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |